Qvtfkiubscgisgnq9wsc rosewell

Hematologic Procurement Shared Resource

ic 9.0/10 Overall Rating No Reviews Yet
ic 3 Orders Completed
Buffalo, New York, US

About Hematologic Procurement Shared Resource

The Roswell Park Hematologic Procurement Bank (formerly known as the Leukemia Tissue Bank and a part of the Pathology Network Shared Resource) provides researchers and investigators with appropriately procured and cryopreserved samples of bone marrow and peripheral blood cells, DNA, RNA, and serum/plasma... Show more »

The Roswell Park Hematologic Procurement Bank (formerly known as the Leukemia Tissue Bank and a part of the Pathology Network Shared Resource) provides researchers and investigators with appropriately procured and cryopreserved samples of bone marrow and peripheral blood cells, DNA, RNA, and serum/plasma samples from patients with hematological malignancies treated at our institute.

Presently, the Bank contains over 100,000 cryopreserved marrow and blood samples from patients with hematological malignancies dating from the present back to 1991 linked to a clinical database. The majority of samples are from patients with acute leukemia. Approximately 70,300 samples from 1,550 individuals with acute myeloid leukemia (AML) and 11,700 samples from 260 patients with acute lymphocytic leukemia (ALL) are currently stored in this shared resource. Samples from patients with myeloid malignancies, chronic leukemias, lymphoproliferative diseases, multiple myeloma, and other hematological disorders are also available.

The Hematological Procurement Bank also contracts with Clinical Research Services to procure, process, and store correlative peripheral blood and other biological samples on patients with a variety of solid and hematological malignancies who are receiving investigational treatment on cancer clinical trials.

Recent Publications

  • Transfer RNA detection by small RNA deep sequencing and disease association with myelodysplastic syndromes. Guo Y, Bosompem A, Mohan S, Erdogan B, Ye F, Vickers KC, Sheng Q, Zhao S, Li CI, Su PF, Jagasia M, Strickland SA, Griffiths EA, Kim AS. BMC Genomics. 2015 Sep 24;16(1):727.
  • Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS. Krönke J, Fink EC, Hollenbach PW, MacBeth KJ, Hurst SN, Udeshi ND, Chamberlain PP, Mani DR, Man HW, Gandhi AK, Svinkina T, Schneider RK, McConkey M, Järås M, Griffiths E, Wetzler M, Bullinger L, Cathers BE, Carr SA, Chopra R, Ebert BL. Nature. 2015 Jul 9;523(7559):183-8.
  • Emadi A, Faramand R, Carter-Cooper B, Tolu S, Ford LA, Lapidus RG, Wetzler M, Wang ES, Etemadi A, Griffiths EA. Presence of isocitrate dehydrogenase (IDH) mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemia. Am J Hematology, 2015 May; 90(5):E77-9. Epub 2015 Feb 27.
  • Pharmacological targeting of β-catenin in normal karyotype acute myeloid leukemia blasts. Griffiths EA, Golding MC, Srivastava P, Povinelli BJ, James SR, Ford LA, Wetzler M, Wang ES, Nemeth MJ. Haematologica. 2015 Feb;100(2):e49-52. Epub 2014 Nov 7.
  • Immunomodulatory action of SGI-110, a hypomethylating agent, in acute myeloid leukemia cells and xenografts. Srivastava P, Paluch BE, Matsuzaki J, James SR, Collamat-Lai G, Karbach J, Nemeth MJ, Taverna P, Karpf AR, Griffiths EA. Leuk Res. 2014 Nov;38(11):1332-41.
  • Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia. Lee HJ, Muindi JR, Tan W, Hu Q, Wang D, Liu S, Wilding GE, Ford LA, Sait SN, Block AW, Adjei AA, Barcos M, Griffiths EA, Thompson JE, Wang ES, Johnson CS, Trump DL, Wetzler M. Cancer. 2014 Feb 15;120(4):521-9.
Show less

Our Services (14)


ic

Blood Banking and Transfusion Medicine

Price on request

Central processing of peripheral blood (PB), plasma, serum, and bone marrow (BM) samples from normal donors and patients with hematological cancers:

  • Isolation of PB/BM mononuclear cells
  • Cryopreserved cells

Central processing of peripheral blood (PB), plasma, serum, and bone marrow (BM) samples from normal donors and patients with hematological cancers:

  • Isolation of PB/BM mononuclear cells
  • Cryopreserved cells
Show less

ic

Bone Marrow Mononuclear Cells

Price on request
Request a quote for more information about this service.

ic

Diseased Human Peripheral Blood Mononuclear Cells (PBMCs)

Price on request
Request a quote for more information about this service.
Acute Myeloid Leukemia (AML) Acute Lymphocytic Leukemia (ALL)

ic

Human Biospecimens

Price on request
Request a quote for more information about this service.

ic

Human Whole Blood & PBMCs

Price on request
Request a quote for more information about this service.

ic

Sequencing data in FASTQ

Price on request
Request a quote for more information about this service.

ic

Biospecimens

Price on request
Request a quote for more information about this service.

ic

Human Primary Cells

Price on request
Request a quote for more information about this service.

ic

Human Biofluids

Price on request

Human Biofluids Services

Human Biofluids Services

Show less

ic

Tissue Processing

Price on request
Request a quote for more information about this service.

ic

Cells and Tissues

Price on request
Request a quote for more information about this service.

ic

Clinical Research

Price on request

Clinical Research Services

Clinical Research Services

Show less

ic

Clinical Laboratory Services

Price on request

Clinical Laboratory Services

Clinical Laboratory Services

Show less

ic

Clinical Hematology

Price on request

Clinical Hematology Services

Clinical Hematology Services

Show less

Not finding what you're looking for?

Get info on this provider's capabilities without requesting a quote.
Missing Avatar

Eunice Wang

Chief, Leukemia Service and Director, Hematologic Procurement Shared Resource

Hematologic Procurement Shared Resource has not received any reviews.

Hematologic Procurement Shared Resource has not received any endorsements.